Margaret Dugan insider trades
Open-market stock purchases and sales by Margaret Dugan, Chief Medical Officer at Whitehawk Therapeutics, Inc, from SEC Form 4 filings since Feb 28, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc | Bought (not open market) | — |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc | Bought (not open market) | — |
| Jun 11, 2026 | ONC BeOne Medicines Ltd | Bought (not open market) | — |
| May 22, 2026 | ONC BeOne Medicines Ltd | Sold | $65.6K |
| May 14, 2026 | WHWK Whitehawk Therapeutics, Inc | Bought (not open market) | $75K |
| Apr 1, 2026 | WHWK Whitehawk Therapeutics, Inc | Bought (not open market) | — |
| Dec 1, 2025 | WHWK Whitehawk Therapeutics, Inc | Bought (not open market) | — |
| Dec 1, 2025 | WHWK Whitehawk Therapeutics, Inc | Bought (not open market) | — |